Healthy adults
Conditions
Sponsors
Miura Clinic, Medical Corporation Kanonkai
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Healthy male and female subjects aged between 20 and 60 (2)Subjects who received sufficient explanation about the purpose and content of the test, had the ability to consent, voluntarily volunteered to participate after understanding it well, and agreed to participate in the test in writing
Exclusion criteria
Exclusion criteria: (1) Subjects with heart, liver, and kidney diseases (including complications of other diseases) (2) Subjects with a history of cardiovascular disease (3) Subjects with diabetes (4) Subjects with diseases currently being treated (5) Subjects who are allergic to food and drugs (6) Subjects with anemia symptoms (7) Subjects who go to the hospital for some illness or are treated with drugs and Chinese medicine (temporary administration is possible) (8) Subjects currently undergoing treatment for dental caries and periodontal disease (9) Subjects with caries (C3 or higher) or severe periodontal disease (10) Subjects who are in the hospital or being treated with drugs or herbal medicine for any disease (can be used additionally) (11) Subjects who play intense sports and subjects who are on a diet (12) Subjects with extremely irregular eating habits (13) Subjects who cannot stop taking health foods (including foods for specified health use and foods with functional claims) and quasi-drugs during the test period (14) Subjects who drink more than 60 g of average daily pure alcohol (15) Subjects who smoke an average of 21 or more cigarettes per day (16) Subjects who are participating in or will participate in other clinical trials at the start of this study (17) Other subjects judged by the investigator or the investigator to be inappropriate for the examination
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Halitosis Tongue coating score judgement Number of oral bacteria | — |
Secondary
| Measure | Time frame |
|---|---|
| Visual Analogue Scale | — |
Countries
Japan
Contacts
Public ContactMakoto Terashima
Oneness Support Co., Ltd. Clinical Trial Division
Outcome results
None listed